Skip to content

H.R. 235 · 118th Congress (2023–2025)

Triple-Negative Breast Cancer Research and Education Act of 2023

This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.

Specifically, the National Institutes of Health must conduct and support research into the disease.

Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.

Show official title

To provide for research and education with respect to triple-negative breast cancer, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 235’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Sheila Jackson Lee (D-TX-18)
Cosponsors
12 cosponsors

0 original · 12 later

1 R · 11 D

  1. Rep. Gwen Moore (D-WI-4)· Later · Oct 10, 2023
  2. Rep. Don Bacon (R-NE-2)· Later · Oct 11, 2023
  3. Rep. Joseph D. Morelle (D-NY-25)· Later · Oct 11, 2023
  4. Rep. Paul Tonko (D-NY-20)· Later · Oct 16, 2023
  5. Rep. Nikema Williams (D-GA-5)· Later · Oct 18, 2023
  6. Rep. Glenn Ivey (D-MD-4)· Later · Oct 25, 2023
  7. Rep. Dwight Evans (D-PA-3)· Later · Oct 26, 2023
  8. Rep. Troy A. Carter (D-LA-2)· Later · Nov 6, 2023
  9. Rep. Jonathan L. Jackson (D-IL-1)· Later · Mar 21, 2024
  10. Rep. Jared Moskowitz (D-FL-23)· Later · Mar 26, 2024
  11. Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Jul 15, 2024
  12. Rep. Terri A. Sewell (D-AL-7)· Later · Jul 15, 2024
Policy area
Health
Subjects
  • Cancer
  • Government information and archives
  • Health information and medical records
  • Health programs administration and funding
  • Health promotion and preventive care
  • Medical education
  • Medical research
  • Minority health
  • 2 more
    • Research administration and funding
    • Women's health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Jan 10, 2023 – Jan 20, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jan 10, 2023
  2. HouseHealthReferred Jan 20, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Triple-Negative Breast Cancer Research and Education Act of 2023

    Display title, Short title · Introduced in House

  2. To provide for research and education with respect to triple-negative breast cancer, and for other purposes.

    Official title · Introduced in House